1. Home
  2. AVBP vs NRDS Comparison

AVBP vs NRDS Comparison

Compare AVBP & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • NRDS
  • Stock Information
  • Founded
  • AVBP 2021
  • NRDS 2009
  • Country
  • AVBP United States
  • NRDS United States
  • Employees
  • AVBP N/A
  • NRDS N/A
  • Industry
  • AVBP
  • NRDS EDP Services
  • Sector
  • AVBP
  • NRDS Technology
  • Exchange
  • AVBP NYSE
  • NRDS Nasdaq
  • Market Cap
  • AVBP 862.8M
  • NRDS 811.4M
  • IPO Year
  • AVBP 2024
  • NRDS 2021
  • Fundamental
  • Price
  • AVBP $18.66
  • NRDS $10.54
  • Analyst Decision
  • AVBP Strong Buy
  • NRDS Buy
  • Analyst Count
  • AVBP 8
  • NRDS 6
  • Target Price
  • AVBP $38.38
  • NRDS $15.17
  • AVG Volume (30 Days)
  • AVBP 239.9K
  • NRDS 397.0K
  • Earning Date
  • AVBP 08-13-2025
  • NRDS 08-07-2025
  • Dividend Yield
  • AVBP N/A
  • NRDS N/A
  • EPS Growth
  • AVBP N/A
  • NRDS N/A
  • EPS
  • AVBP N/A
  • NRDS 0.38
  • Revenue
  • AVBP N/A
  • NRDS $734,900,000.00
  • Revenue This Year
  • AVBP N/A
  • NRDS $18.07
  • Revenue Next Year
  • AVBP N/A
  • NRDS $8.22
  • P/E Ratio
  • AVBP N/A
  • NRDS $27.91
  • Revenue Growth
  • AVBP N/A
  • NRDS 24.20
  • 52 Week Low
  • AVBP $15.47
  • NRDS $7.55
  • 52 Week High
  • AVBP $36.37
  • NRDS $16.45
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 29.95
  • NRDS 44.50
  • Support Level
  • AVBP $21.10
  • NRDS $10.75
  • Resistance Level
  • AVBP $22.29
  • NRDS $11.12
  • Average True Range (ATR)
  • AVBP 1.02
  • NRDS 0.31
  • MACD
  • AVBP -0.29
  • NRDS -0.02
  • Stochastic Oscillator
  • AVBP 2.38
  • NRDS 36.38

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About NRDS NerdWallet Inc.

Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.

Share on Social Networks: